These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20021073)

  • 1. CYP450, COX-2 and Obesity Related Renal Damage.
    Imig JD; Zhao X; Dey A; Shaw M
    Toxicol Mech Methods; 2005; 15(2):125-36. PubMed ID: 20021073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rofecoxib decreases renal injury in obese Zucker rats.
    Dey A; Maric C; Kaesemeyer WH; Zaharis CZ; Stewart J; Pollock JS; Imig JD
    Clin Sci (Lond); 2004 Dec; 107(6):561-70. PubMed ID: 15307815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARs and the kidney in metabolic syndrome.
    Ruan X; Zheng F; Guan Y
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1032-47. PubMed ID: 18234957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosanoids and renal vascular function in diseases.
    Imig JD
    Clin Sci (Lond); 2006 Jul; 111(1):21-34. PubMed ID: 16764555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal functional effects of endothelins: dependency on cytochrome P450-derived arachidonate metabolites.
    Oyekan AO; McAward K; McGiff JC
    Biol Res; 1998; 31(3):209-15. PubMed ID: 9830508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and chronic kidney disease.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Pirulli A; Barazzoni R
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S19-23. PubMed ID: 20797564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gonadectomy on the metabolism of arachidonic acid in isolated kidney of a rat model of metabolic syndrome.
    Pérez-Torres I; El Hafidi M; Pavón N; Infante O; Avila-Casado MC; Baños G
    Metabolism; 2010 Mar; 59(3):414-23. PubMed ID: 19801156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats.
    Tofovic SP; Dubey RK; Jackson EK
    J Pharmacol Exp Ther; 2001 Dec; 299(3):973-7. PubMed ID: 11714885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in renal haemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases.
    Caron N; El Hajjam A; Declèves AE; Joly E; Falck JR; Kramp R
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):683-90. PubMed ID: 15554908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal manifestations in the metabolic syndrome.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
    Dawood T; Schlaich MP
    Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of obesity and chronic kidney disease.
    Ross WR; McGill JB
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):325-35. PubMed ID: 17045219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity in renal failure--health or disease?
    Stolic R
    Med Hypotheses; 2010 Dec; 75(6):497-500. PubMed ID: 20656410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats.
    Zhang X; Jia Y; Jackson EK; Tofovic SP
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):56-63. PubMed ID: 17261964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early renal injury induced by caffeine consumption in obese, diabetic ZSF1 rats.
    Tofovic SP; Salah EM; Jackson EK; Melhem M
    Ren Fail; 2007; 29(7):891-902. PubMed ID: 17994459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome, cardiovascular disease, and risk for chronic kidney disease in an Italian cohort: analysis of the INCIPE study.
    Ferraro PM; Lupo A; Yabarek T; Graziani MS; Bonfante L; Abaterusso C; Gambaro G;
    Metab Syndr Relat Disord; 2011 Oct; 9(5):381-8. PubMed ID: 21711121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.